Eurofins-Cerep Logo

Eurofins-Cerep

Contract research organization for pre-clinical in vitro drug discovery services.

ALECR | PA

Overview

Corporate Details

ISIN(s):
FR0004042232 (+3 more)
LEI:
9695004C9D3ZX7FTZY16
Country:
France
Address:
2 RUE DU PROFESSEUR GARGOUIL, 86600 CELLE-LEVESCAULT

Description

Eurofins-Cerep is a Contract Research Organization (CRO) specializing in pre-clinical drug discovery services. The company provides solutions for in vitro drug profiling and screening in pharmacology, supporting pharmaceutical, biopharmaceutical, and biotechnology companies in the early stages of new drug development. Its services focus on delivering critical data regarding the biological activity and potential liabilities of chemical compounds, which aids clients in the identification and optimization of promising drug candidates before they proceed to clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-06-15 08:30
Cerep announces Kinase profiling agreement with Lilly
English 56.5 KB
2009-06-15 08:30
Cerep et Lilly signent un accord de profilage sur kinases
French 56.3 KB
2009-05-15 18:00
Assemblée générale mixte (ordinaire et extraordinaire) du vendredi 19 juin 2009…
French 39.1 KB
2009-05-13 18:30
Rapport financier annuel 2008
French 825.0 KB
2009-05-04 17:45
First quarter 2009 sales revenues
English 61.0 KB
2009-05-04 17:45
Information financière trimestrielle / Premier trimestre 2009
French 60.6 KB
2009-04-29 17:30
Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2008
French 53.7 KB
2009-04-28 07:45
Cerep et PerkinElmer annoncent l’extension de leur portefeuille de nouvelles ki…
French 100.1 KB
2009-04-28 07:45
PerkinElmer and Cerep announce expansion of new kinase assay offerings to accel…
English 99.4 KB
2009-03-24 18:00
2008 consolidated results
English 535.2 KB
2009-03-23 19:30
Résultats consolidés 2008
French 542.9 KB
2009-02-12 19:30
Cerep announces sales revenues for 2008
English 87.8 KB
2009-02-12 19:15
Cerep annonce son chiffre d’affaires 2008
French 94.7 KB
2009-01-07 11:00
Cerep signs a license agreement with Théa for the development of its LFA-1 anta…
English 58.3 KB
2009-01-07 11:00
Cerep annonce la signature d’un accord de licence avec Théa pour le développeme…
French 57.2 KB

Automate Your Workflow. Get a real-time feed of all Eurofins-Cerep filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurofins-Cerep

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurofins-Cerep via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.